2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow amlexanox: new trials by email Literature Review of amlexanox trials Research Report on amlexanox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients Amlexanox, Placebo - Diabetes Mellitus Type 2, Non-alcoholic Fatty Liver Disease | Phase 2 | Completed | University of Michigan | 42 | 2014-01-01 | 2018-11-07 |
| Amlexanox for Type 2 Diabetes and Obesity Amlexanox - Diabetes Mellitus Type 2, Non Alcoholic Fatty Liver Disease | Phase 2 | Terminated | University of Michigan | 7 | 2013-07-19 | 2024-05-07 |
| Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region amlexanox, Vehicle rinse - Oral Mucositis | Phase 2 | Completed | Access Pharmaceuticals, Inc. | 58 | 2000-02-01 | 2010-03-18 |
Diabetes Mellitus, Type 2 (2) · Non-alcoholic Fatty Liver Disease (2) · Obesity (2) · Mucositis (1) · Stomatitis (1)
University of Michigan (2) · Access Pharmaceuticals, Inc. (1)
United States (3)
Elif A Oral, MD (1) · Paul Busse, M.D., Ph.D. (1)